SecBot SecBot
DEFA14A ·Filed Apr 20, 2026

ADCT

ADC Therapeutics SA
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0000950103-26-005918
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine proxy filing with no material impact on the company's operations or financials. Monitor for the next 10-Q for any updates on financial performance.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ADCT ▼ -69.88% at T+60d
NEUTRAL call -69.88% · α vs SPY -76.66% · entry $4.25 → $1.28
Entry = T+0 close
Apr 20, 2026
via day close
T+1d
-3.29%
call -3.29% · α -2.64%
$4.11
settled 6mo ago
T+5d
-11.53%
call -11.53% · α -12.44%
$3.76
settled 6mo ago
T+20d
-25.41%
call -25.41% · α -29.61%
$3.17
settled 5mo ago
T+60d
-69.88%
call -69.88% · α -76.66%
$1.28
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

ADC Therapeutics SA (ADCT) has filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting, which is a routine filing for public companies to solicit votes on corporate governance matters. The filing is routine and does not contain any material financial information or significant corporate actions.

Key Financial Metrics

Vote
director election
Meeting
2026-04-20

Key Facts

  • The filing is a DEFA14A proxy statement for ADC Therapeutics SA (ADCT)
  • This is a routine filing for a shareholder meeting, which is a standard corporate governance process
  • The filing does not contain any financial data, strategic announcements, or material corporate actions
  • There are no activist campaigns or contested board seats mentioned in the filing

Financial Impact

No financial impact

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0000950103-26-005918
Document: 0000950103-26-005918-index-headers.html0000950103-26-005918
Document: 0000950103-26-005918-index.html0000950103-26-005918
Document: 0000950103-26-005918.txt0000950103-26-005918
8 reports for ADCT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ADCT — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
8-K
BULLISH ★ 7/10
$1.70 $1.52▼ −10.59%▼ −9.44%$1.51 (−11.18%)
Aug 6, 2026
11w ago
Press Release
NEUTRAL ★ 1/10
$1.13 $1.05▼ −7.08%▼ −8.29%$1.51 (+33.63%)
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$1.19 $1.30▲ +9.24%▲ +8.31%$1.51 (+26.89%)
Jun 3, 2026
20w ago
8-K
MIXED ★ 6/10
$1.32 $1.06▼ −19.70%▼ −17.14%$1.51 (+14.39%)
May 4, 2026
25w ago
8-K
NEUTRAL ★ 4/10
$3.68 $3.48▼ −5.43%▼ −8.37%$1.51 (−58.97%)
Apr 20, 2026
27w ago
DEFA14A
NEUTRAL ★ 2/10
$4.25 $3.76▼ −11.53%▼ −12.44%$1.51 (−64.47%)
Mar 17, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
$4.11 $3.94▼ −4.14%▼ −1.48%$1.51 (−63.26%)
Mar 10, 2026
32w ago
S-3
BEARISH ★ 6/10
$4.88 $4.01▲ +17.83%▲ +15.64%$1.51 (+69.06%)
Showing 8 of 8

US Market Status

Market Closed — Opens Tue (15h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026